Sino Biopharmaceutical (OTCMKTS:SBMFF) Trading Down 8.5% – Time to Sell?

Sino Biopharmaceutical (OTCMKTS:SBMFF)’s share price dropped 8.5% during mid-day trading on Monday . The stock traded as low as $0.6959 and last traded at $0.6959. Approximately 604 shares changed hands during trading, a decline of 55% from the average daily volume of 1,350 shares. The stock had previously closed at $0.7602.

Sino Biopharmaceutical Trading Down 8.5%

The company’s fifty day moving average is $0.79 and its 200-day moving average is $0.84.

About Sino Biopharmaceutical

Sino Biopharmaceutical Limited (OTCMKTS: SBMFF) is a Hong Kong–incorporated investment holding company principally engaged in the pharmaceutical sector. Founded in 2000 and listed on the Hong Kong Stock Exchange in 2006, the company has developed an integrated business model that spans research and development, manufacturing and commercialization of healthcare products. Through its subsidiaries, Sino Biopharmaceutical focuses on enhancing China’s domestic pharmaceutical infrastructure while expanding its footprint across key therapeutic areas.

The company’s product portfolio is organized into three core segments: infusion solutions, small-molecule synthetic pharmaceuticals and innovative biologics.